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Bovine papular stomatitis virus (BPSV) and orf virus (ORFV), members of the genus Parapoxvirus of the
Poxviridae, are etiologic agents of worldwide diseases affecting cattle and small ruminants, respectively. Here
we report the genomic sequences and comparative analysis of BPSV strain BV-AR02 and ORFV strains
OV-SA00, isolated from a goat, and OV-IA82, isolated from a sheep. Parapoxvirus (PPV) BV-AR02, OV-SA00,
and OV-IA82 genomes range in size from 134 to 139 kbp, with an average nucleotide composition of 64% GC.
BPSV and ORFV genomes contain 131 and 130 putative genes, respectively, and share colinearity over 127
genes, 88 of which are conserved in all characterized chordopoxviruses. BPSV and ORFV contain 15 and 16
open reading frames (ORFs), respectively, which lack similarity to other poxvirus or cellular proteins. All genes
with putative roles in pathogenesis, including a vascular endothelial growth factor (VEGF)-like gene, are
present in both viruses; however, BPSV contains two extra ankyrin repeat genes absent in ORFV. Interspecies
sequence variability is observed in all functional classes of genes but is highest in putative virulence/host range
genes, including genes unique to PPV. At the amino acid level, OV-SA00 is 94% identical to OV-IA82 and 71%
identical to BV-AR02. Notably, ORFV 006/132, 103, 109, 110, and 116 genes (VEGF, homologues of vaccinia
virus A26L, A33R, and A34R, and a novel PPV ORF) show an unusual degree of intraspecies variability. These
genomic differences are consistent with the classification of BPSV and ORFV as two PPV species. Compared
to other mammalian chordopoxviruses, PPV shares unique genomic features with molluscum contagiosum
virus, including a GC-rich nucleotide composition, three orthologous genes, and a paucity of nucleotide
metabolism genes. Together, these data provide a comparative view of PPV genomics.
Parapoxviruses (PPVs) represent one of the eight genera
within the chordopoxvirus (ChPV) subfamily of the Poxviridae
and include orf virus (ORFV), bovine papular stomatitis virus
(BPSV), pseudocowpoxvirus (PCPV), PPV of red deer in New
Zealand, and PPV of the grey seal (6, 51, 57, 65). Tentative
members of the genus cause disease in camels and red squirrels
(14, 68). Features that distinguish PPVs from other poxvirus
genera are the ovoid virion shape, the crisscross pattern on the
particle surface, and the relatively small size and high GC
content of the genome (55, 86; this report).
PPVs cause nonsystemic, eruptive skin disease in domestic
and wild mammals. ORFV, the prototype species of PPV, is
responsible for contagious ecthyma, an acute disease of sheep
and goats. The disease, also known as orf, contagious pustular
dermatitis, or scabby mouth, is characterized by proliferative
lesions in the skin of the lips, around the nostrils, and in the
oral mucosa (27). Lesions progress through a typical pattern of
erythema, papula, pustule, and scab and usually resolve in 1 to
2 months (45). Although considered a mild disease, mortality
rates up to 93% have been reported in kids (41). High mor-
tality rates occur when lesions in lips and udders prevent in-
fected animals from suckling and grazing, resulting in rapid
emaciation (13, 41, 58). Sheep can be repeatedly infected with
ORFV, albeit with shorter times to recovery and less pro-
nounced pathological changes than in a primary infection (45).
A Th1-type immune response has been implicated in host
immunity to ORFV infection (reviewed in reference 32). At-
tenuated orf vaccines can limit the severity of the infection but
they are unable to completely prevent the disease (30).
BPSV infects cattle of all ages but clinical signs are usually
seen in calves. The disease has a worldwide distribution and is
characterized by papules, often mildly erosive, on the muzzle,
oral mucosa, and udder and occasionally in the esophagus and
forestomach (40). Like ORFV in sheep and goats, reinfection
of cattle with BPSV is commonly observed, suggesting that
virus infection does not confer significant immunity. Because
of its clinical resemblance to foot-and-mouth disease, BPSV
infections are reported to veterinary authorities for differential
diagnosis.
Cocirculation of BPSV and ORFV in wild ruminants has
been described (35), and PPV isolates from wild ruminants
have been experimentally transmitted to sheep, goats, and cat-
tle (59, 60). Both ORFV and BPSV cause occupational infec-
tions in humans with lesions characterized by large, painful
nodules in the hands and, less frequently, the face (8, 47, 69).
Classification of PPVs has relied on natural host range,
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pathology, and viral DNA restriction enzyme analysis. The
latter revealed considerable genomic heterogeneity, even be-
tween isolates of the same virus (26, 35, 63, 64). Hybridization
analysis of viral DNA indicates that internal but not terminal
genomic regions are conserved between PPVs (26). Data con-
cerning PPV genomics, largely obtained by using ORFV strain
NZ2, has revealed (i) colinearity between the ORFV and other
poxvirus genera genomes (21, 49, 50), (ii) the presence of a set
of genes mostly located at the termini of the viral genome with
putative or known roles in virulence or immunomodulation
(15, 23, 38, 42, 76), and (iii) the occurrence of genomic rear-
rangements of the termini upon serial virus passage in vitro
(12, 22). Less is known about the gene complement and
genomic organization of other PPV. DNA sequencing of the
right end of the BPSV strain B177 genome indicated an orga-
nization similar to that of the right end of the ORFV genome,
except for the lack of a vascular endothelial growth factor
(VEGF) gene in BPSV (67). Here we present the complete
DNA sequences of two ORFV isolates and one BPSV isolate,
thus providing an overview of PPV genomic organization and
gene content as well as a comparison between the two viruses.
MATERIALS AND METHODS
Virus strains. ORFV strain SA00 (OV-SA00) was isolated in Texas from scab
material collected from a kid with severe multifocal, proliferative dermatitis and
propagated in Madin-Darby ovine kidney cells (29). ORFV strain IA82 (OV-
IA82) is a field isolate obtained from nasal secretions of a lamb at the Iowa Ram
Test Station during an orf outbreak in 1982 and was passaged in ovine fetal
turbinate cells. BPSV strain AR02 (BV-AR02) was isolated from a 3-week-old
calf with oral lesions in Arkansas and passaged in primary lamb kidney cells.
Viral DNA isolation, cloning, sequencing, and sequence analysis. Viral
genomic DNA was extracted from infected primary lamb kidney cell cultures as
previously described (82). Random DNA fragments were obtained by incom-
plete enzymatic double digestion with AciI and TaqI endonucleases (New En-
gland Biolabs, Beverly, Mass.), and DNA fragments larger than 1.0 kbp were
cloned and used in dideoxy sequencing reactions as previously described (2).
Reaction products were analyzed on an ABI Prism 3700 automated DNA se-
quencer (Applied Biosystems, Foster City, Calif.). Sequence data were assem-
bled with the Phrap and CAP3 software programs (18, 19, 33), and gaps were
closed as described previously (1). The final DNA consensus sequences for each
genome represented on average seven- to ninefold redundancy at each base
position and a Consed estimated error rate of 0.01 per 10 kbp (18, 19, 28).
Genome DNA composition, structure, repeats, and restriction enzyme pat-
terns were analyzed as previously described (1) with the Genetics Computer
Group GCG version 10 software package (16). Pairwise genomic alignments
were done with WABA (http://www.cse.ucsc.edu/kent/), and multiple genomic
alignments were done with Dialign (54) and Clustal (77) alignment programs.
Open reading frames (ORFs) longer than 30 codons were evaluated for coding
potential and ORFs greater than 60 codons were subjected to homology searches
as previously described (1, 2). In addition, Framefinder (http://www.hgmp.mrc.ac
.uk/gslater) was used to evaluate coding potential. Based on these criteria, 131
(BPSV) and 130 (ORFV) putative genes were annotated and orthologous ORFs
were similarly numbered. Phylogenetic comparisons were done with the PHY-
LO_WIN software package (25) and Puzzle (75).
Nucleotide sequence accession number. The genome sequences of ORFV
strains IA82 and SA00 and BPSV strain AR02 have been deposited in GenBank
under accession no. AY386263, AY386264, and AY386265, respectively.
RESULTS AND DISCUSSION
BPSV and ORFV genomes. Genome sequences of BV-
AR02, OV-SA00 and OV-IA82 were assembled in contiguous
sequences of 134431, 139962, and 137241 bp, respectively. This
agrees with previous restriction enzyme-based size estimates
for both viruses (26, 48, 63). Variable genome sizes are com-
mon between PPV isolates, especially in BPSV, where differ-
ences up to 17 kb have been reported (26, 64). Hairpin loop
sequences at the end of the genomes were not sequenced, and
the left-most nucleotide of each assembled genome was arbi-
trarily designated base 1. Nucleotide composition averaged
64% GC for each of the three isolates analyzed here. This
content is not uniformly distributed along the entire genome,
with a GC content lower than 50% being found in both
coding (e.g., ORFs 127 and 006/132) and intergenic regions.
Like other poxviruses, BPSV and ORFV genomes contain a
large central coding region bounded by two identical inverted
terminal repeat (ITR) regions (12, 26, 48). Assembled ITRs of
BV-AR02, OV-SA00, and OV-IA82 contain 1,161, 3,936, and
3,092 bp, respectively. The differences in length between the
ITRs of OV-SA00 and OV-IA82 strains are in agreement with
previous work, indicating natural intrastrain variations in this
genomic region (64). Only one ORF (001), previously de-
scribed for ORFV strains NZ2 and NZ7 (20, 24) and in BPSV
strain B177 (67), initiates and is completely located within the
ITRs in the three virus isolates. This ORF of unknown func-
tion is unique to BPSV and ORFV, sharing 63% amino acid
identity. Putative transcription control elements similar to
those described for the ORFV strain NZ2 homologue are
found flanking BPSV 001, suggesting early gene expression, as
is the case for ORFV NZ2 (20). A second ORFV gene of
unknown function (002), not present in BPSV, initiates within
the unique region and terminates within the ITR.
Despite the high GC content and paucity of stop codons,
which yield 362 and 345 methionine-initiated ORFs of at least
60 codons in BPSV and ORFV genomes, respectively, coding
potential analysis and similarity to known proteins led us to
conservatively predict 131 genes in BPSV and 130 genes in
ORFV. These genes, which encode proteins of 53 to 1289
amino acids, represent an approximate coding density of 90%
for BPSV and 95% for ORFV (Table 1). The central genomic
core region (ORFs 009 to 111) contains homologues of con-
served poxvirus genes involved in basic replicative mechanisms
and structure and morphogenesis of intracellular mature and
extracellular enveloped virions (EEV) (55) (Table 1). Homo-
logues of vaccinia virus (VACV) F9L and F10L, which are
located at the left end of the conserved core in most ChPVs,
are located at the right end of PPV genomes (ORFs 130 and
131). Terminal genomic regions (ORFs 001 to 008 and 112 to
134) represent approximately 20% of the viral genome and
contain genes likely affecting pathogenesis. These include
genes potentially involved in host range (ankyrin repeat pro-
teins; ORFs 003, 004, 008, 118, 123, 126, 128, and 129), im-
mune evasion (ORF 127), and immune modulation (ORF 117)
and genes affecting virulence (ORF 006/132). Notably, PPVs
contain a dUTPase gene previously characterized in ORFV
(22, 43) but lack homologues of other ChPV genes likely in-
volved in nucleotide metabolism, making this class of genes
underrepresented in PPVs.
Comparison of BPSV with ORFV. At the genomic level,
BPSV and ORFV genomes share 67 to 75% nucleotide iden-
tity (versus 94% between the two ORFV strains) and contain
127 genes with the same relative order and orientation, of
which 15 are unique to PPVs. These features support the
inclusion of BPSV and ORFV in the same genus. BV-AR02
and OV-SA00 demonstrate average amino acid identities of
71% (versus 94% between OV-SA00 and OV-IA82), consis-
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tent with the classification of BPSV and ORFV as two PPV
species. BPSV and ORFV share 44, 58, and 27 genes with 81
to 100%, 61 to 80%, and 29 to 60% amino acid identity,
respectively. About half of the most similar ORFs (81 to 100%
amino acid identity) are associated with transcription, tran-
scription regulation, or RNA processing (Table 1).
BPSV and ORFV contain 15 and 16 ORFs, respectively,
which share no significant homology to known proteins and are
primarily located at the right end of the genome. Fourteen of
these ORFs (ORFs 001, 005, 012, 013, 024, 073, 113, 115, 116,
119 to 121, 124, and 125) are present in both BPSV and
ORFV, with amino acid identities ranging from 29 to 64%, two
(ORFs 002 and 118) are present only in ORFV, and one (ORF
133) is unique to BPSV. Consistent with a possible host range
function, homologues of six of these (ORFs 012, 024, 118, 119,
121, and 125) are transcribed at early times in cells infected
with ORFV strain orf-11 (Table 1).
Of the 26 most distantly related ORFs between BPSV and
ORFV (amino acid identity  60%), 10 are unique to PPVs
(ORFs 005, 012, 013, 113, 115, 116, 119 to 121, and 124), 3 are
characterized ORFV NZ2 strain genes with putative (ORFs
020 and 117) or known (ORF 006/132) roles in pathogenesis,
10 show homology with VACV genes of known structure or
function (ORFs 061, 080, 088, 103, 109, 110, 112, 126, 128, and
129), and 3 show homology with VACV virus ORFs of un-
known function (ORFs 009, 016, and 122).
Highly variable PPV proteins include homologues of the
VACV proteins H5R, A4L, A12L, A26L, A33R, A34R, M1L,
and B4R. BPSV and ORFV 061, orthologues of VACV H5R
gene, are only 51% identical. H5R encodes a late transcription
factor (VLTF-4) which is synthesized before and after DNA
synthesis, is phosphorylated by viral kinases, and is hypothe-
sized to have multiple roles in the viral replicative cycle (5, 36).
Notably, in closely related capripoxviruses, sheeppox virus and
goatpox virus (genomes which share 96% nucleotide identity),
VLTF-4 homologues are among the least conserved genes. It is
tempting to speculate that PPV ORF 061 may play a role in
host range during virus infection.
BPSV and ORFV 080 encode homologues of VACV A4L, a
gene with significant variability in other poxvirus genera. A4L
encodes an immunodominant late protein associated with the
virion core and necessary for viral morphogenesis (84). OV-
SA00 and OV-IA82 080 encode products that are 84 and 80
amino acids longer than the BPSV 080 product, respectively,
due in part to the lack of four Cys-(Pro-Ala)3 motifs separated
by additional Pro/Ala-rich sequences in BPSV 080. Similar
Pro/Ala-rich repeats are present in the molluscum contagio-
sum virus (MOCV) orthologue MC107L but not in A4L. Tan-
dem repeat motifs in A4L-like proteins are thought to be
involved in protein-protein interactions and antigenicity (7).
BPSV and ORFV 088, orthologues of VACV A12L virion
core protein, share only 56% amino acid identity, an unusual
degree of intragenus variability for A12L orthologues (e.g.,
90% amino acid identity within orthopoxvirus [OPV], lepo-
ripoxvirus, and capripoxvirus). Notably, BPSV and ORFV 088
encode proteins of 223 and 260 amino acid, respectively, while
non-PPV ChPV A12L orthologues are 156 to 195 amino acids.
The difference in length is partially due to a positively charged
20-residue insertion immediately downstream of the predicted
VNA/GG cleavage site (position 170 in ORFV 088) and might
suggest specific PPV core structure requirements (83).
PPV 102 and 103 are variable ORFs, with PPV 102 being
more conserved between species than 103 (67 to 76% versus 57
to 58% amino acid identity, respectively). PPV 102 and 103
share similarity to each other (32 to 37% amino acid identity)
and to homologues of OPV genes involved in formation of
virus-filled A-type inclusions (ATIs) (46, 80). Both 102 and 103
are most similar to homologues of OPV P4c, an intracellular
mature virion (IMV)-specific protein which helps direct IMV
into ATIs. The carboxy termini of PPV 102 and OPV P4c
proteins share sequences found in the VACV A27L fusion
protein. PPV 103 has weak similarity to OPV ATI proteins,
which constitute the crystalline matrix of OPV ATIs. Given the
variable nature of these genes in different ChPV genera, PPV
homologues may affect genera-specific and species-specific
mechanisms of retaining or disseminating IMVs.
PPV 109 and 110 are orthologues of VACV A33R and
A34R, respectively, genes encoding envelope type II glycopro-
teins expressed in intracellular enveloped virions and in EEV
(44, 66). Mutations in these genes affect EEV formation
(A33R and A34R), cell-to-cell spread of virus (A33R), and
infectivity and virulence (A34R) (reviewed in reference 74).
PPV 109 and 110, although distantly related to the VACV
orthologues, are predicted to contain amino-terminal trans-
membrane regions and external Cys residues suggesting a sim-
ilar protein topology and structure. Notably, OV-SA00 109 and
110 are as distantly related to OV-IA82 orthologues (56 and
49% amino acid identity) as they are to BPSV proteins (49 to
50% amino acid identity) (Table 1), with amino acids differ-
ences being largely concentrated in the predicted external do-
main. An explanation for this intraspecies variability is not
immediately obvious. Alignment of available ORFV 109 se-
quences grouped OV-IA82, NZ2, and Orf-11 A33R homo-
logues in a single cluster with 80 to 97% amino acid identity,
excluding OV-SA00 A33R, which showed 51 to 55% amino
acid identity relative to other ORFV sequences. A similar
situation is observed when available ORF 110 sequences are
compared. OV-SA00 is the only strain originally isolated from
goats, whereas OV-IA82, NZ2, and ORF-11 strains were iso-
lated from sheep. Thus, there appears to be a correlation
between the species from which the virus was isolated and
clustering of ORFV 109 and 110 amino acid sequences. This
raises the possibility that differences in the external domain of
both A33R and A34R are associated with host-specific require-
ments during virus infection by EEV. Differences in disease
course have been shown following experimental infection with
ORFV isolated from sheep or goats (87).
Variable PPV 126, 128, and 129 correspond to the Ank-1,
Ank-2, and Ank-3 genes previously described for the BPSV
B177 and ORFV D1701 strains (67). These ORFs are 58, 57,
and 50% identical between BPSV and ORFV, respectively,
and encode ankyrin repeat-containing proteins (ARPs). Cellu-
lar ARPs engage other proteins to form regulatory complexes
which are involved in the control of processes such as cell cycle
and cell differentiation (71). Many poxviruses encode ARPs,
several of which have been linked to host range functions,
apoptosis inhibition, and virulence (34, 56). Notably, BPSV
contains two additional ARPs in the left terminal genomic
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region (ORFs 003 and 004) which are not present in ORFV
(Table 1).
PPV genes involved in pathogenesis. ORFV encode several
proteins with known or putative roles in pathogenesis: 020, an
orthologue of vaccinia E3L that functions in interferon (IFN)
resistance; 127, a viral homologue of IL-10; 117, a secreted
granulocyte-macrophage colony-stimulating factor (GM-CSF)
inhibitor (GIF); 112, a putative chemokine-binding protein;
and 132, a viral homologue of VEGF. These genes are present
in BPSV with predicted amino acid identities ranging from 37
to 77%.
E3L encodes a double-stranded-RNA (dsRNA)-binding
protein kinase inhibitor with orthologues in all ChPV genera
except Avipoxvirus and Molluscipoxvirus. The E3L gene prod-
uct provides IFN resistance to VACV-infected cells and broad
host range to virus infection in tissue culture and is a virulence
determinant (4, 9). The ORFV NZ2 strain E3L homologue is
also involved in IFN resistance (31) and is 93% and 53%
identical to its OV-SA00 and BPSV counterparts, respectively.
ORFV and BPSV 020 are most similar at the carboxy-terminal
half of the protein, which is predicted to bind dsRNA through
a conserved binding motif (10). The amino-terminal half of the
protein is less conserved (45% amino acid identity) and in-
cludes two deletions of six and four amino acids in ORFV. In
VACV, the amino-terminal half of E3L is dispensable for
replication in cell culture and is not required for IFN resis-
tance. However, this region is required for full virulence in a
mouse intranasal inoculation model (9). It is thus possible that
differences between ORFV and BPSV in the amino-terminal
half of 020 are significant for host range and pathogenesis in
their respective hosts.
OV-SA00 and OV-IA82 127 are orthologues (95% amino
acid identity) of the previously described ORFV NZ2 and NZ7
strain IL-10 genes (23). BV-AR02 127 is divergent from
ORFV homologues (77% amino acid identity) with most
amino acid differences concentrated in the amino terminal
third of the protein (27% amino acid identity in the first 50
amino acids). Nevertheless, a putative signal peptide is present
in the amino terminus of all three IL-10 homologues presented
here. The carboxy two-thirds of PPV IL-10 are highly con-
served with cellular IL-10, with all ORFV interleukin 10 (IL-
10) proteins sequenced to date being most similar to ovine
IL-10 (23; this work). Notably, and in agreement with previous
results, BV-AR02 127 shares in this conserved region six res-
idues identical to bovine but not to ovine and ORFV IL-10,
including a His residue at position 75 predicted to interact with
the IL-10 receptor chain 1 (67). These features may reflect
specific adaptation to the natural host.
PPVs 117 are orthologues of ORFV GIF, a protein which
binds and inhibits GM-CSF and IL-2 in vitro and may function
as an immunomodulatory factor in vivo (15). OV-SA00, OV-
IA82, and NZ2 strain GIF homologues are very similar to each
other (94% amino acid identity), containing at least six poten-
tially structurally significant Cys residues and an amino-termi-
nal signal peptide. While BV-AR02 GIF shares these struc-
tural features, it is only 38 to 40% identical to ORFV GIF, an
unexpected divergence considering the similarity between
ovine and bovine GM-CSF and IL-2 (83 and 96% amino acid
identity, respectively). Notably, PPV 117 shares 22 to 25%
amino acid identity with PPV 112, a gene also predicted to
encode a signal peptide and expressed at early times postin-
fection in ORFV strain Orf-11 (Table 1). Both PPV 117 and
112 share limited sequence similarity and/or Cys patterns with
VACV C23L and myxoma virus MT-1 chemokine binding pro-
teins and VACV A41L virulence factor. Taken together, these
data suggest that PPV 117 and 112 may be members of a
divergent family of poxviral chemokine- and cytokine-binding
virulence factors.
ORFV 132 and BPSV 006 encode homologues of mamma-
lian VEGFs, angiogenic factors that bind receptor tyrosine
kinases to affect embryonic development and tumor neovascu-
larization (11, 53, 62, 85). ORFV, PCPV, and BPSV encode
the only known viral VEGFs (vVEGFs), all of which contain a
characteristic cystine knot motif, a potential signal sequence,
potential N- and O-linked glycosylation sites, a carboxy-termi-
nal Thr/Pro-rich motif unique to vVEGFs, and an Asp residue
(position 85 in BPSV VEGF) associated with specific VEGF
receptor binding (38, 79; this paper). All vVEGFs are flanked
by similar putative transcriptional control elements (38, 79; this
paper) suggesting that, as is the case for ORFV (38), these
genes are expressed at early times postinfection. ORFV VEGF
is known to play a role in ORFV pathogenesis associated with
vascularization and epidermal lesion proliferation (70).
OV-SA00 and OV-IA82 VEGF are 38% identical to each
other and most similar to NZ7 and NZ2-like VEGFs (90 and
80% amino acid identity, respectively). Previous sequence
analysis of ORFV isolates from diverse geographic origins
segregated VEGFs into two divergent groups, a more con-
served NZ7-like group and a more variable NZ-2 group (52).
The data presented here for U.S. ORFV isolates further sup-
ports the notion that VEGF type is independent of the geo-
graphic origin (52).
BV-AR02 006 represents a novel variant of PPV VEGF,
previously not found in BPSV strain B177 by DNA hybridiza-
tion (67). BV-AR02 006 is located in a BPSV-specific, left
terminal genomic region contrasting the right terminal loca-
tion of ORFV and PCPV VEGFs. BV-AR02 VEGF is 35 to
50% identical to other vVEGFs and contains a unique charged
pentapeptide located at positions 34 to 39. This suggests that,
as for PCPV, BPSV VEGF is distinct from ORFV VEGF
prototypes. Sequence divergence revealed here may explain
the lack of hybridization when BPSV B177 strain DNA was
probed with ORFV VEGF probe (67). Alternatively, terminal
genomic variability observed for BPSV isolates (26) may have
resulted in loss of the gene from the B177 strain. The presence
of vVEGF in BPSV suggests its importance in PPV pathogen-
esis; however, the divergent nature of BPSV VEGF may imply
functions or binding specificities distinct from other vVEGFs.
Comparison of PPV with other poxvirus genera. BPSV and
ORFV contain 16 and 17 ORFs, respectively, which have no
significant homology to genes from other poxvirus genera, and
with the exception of VEGF, to other known proteins (Table
1). Although six of them are transcribed in ORFV strain Orf-
11-infected cell cultures, their functions are not known. BPSV
and ORFV contain a total of 113 and 111 genes, respectively,
with homology to genes from other poxvirus genera. These
include homologues of 88 of the 90 genes conserved within all
other ChPVs, with 7 of the 11 most similar (60% amino acid
identity; Table 1) involved in transcription, indicating that
PPVs utilize basic ChPV replicative mechanisms (81). PPVs
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are unique within the ChPV subfamily in that they lack homo-
logues of VACV F15L, a gene of unknown function, and
VACV D9R, a gene encoding a putative nucleoside triphos-
phate pyrophosphohydrolase containing a mutT motif similar
to that in VACV D10R, a protein affecting viral transcription
(55).
PPVs, although distinct, share a number of features with
MOCV, the sole member of the molluscipoxvirus genus. PPV
and MOCV are the only characterized poxviruses with ge-
nomes rich in GC (64%), while others are rich in AT.
Homology searches revealed that 46 of 104 PPV proteins were
most similar to MOCV orthologues, while 26 proteins were
more similar to OPV orthologues (Table 1 and data not
shown).
PPV 014, 015, and 029 are putative orthologues of MOCV
MC026L, 027L, and 043L, respectively, based on amino acid
identity and similar genomic location (72, 73). These ORFs of
unknown function have no counterparts outside PPV and
MOCV and are 61 to 68% identical between ORFV and
BPSV. PPV 029 is transcribed at early times postinfection in
Orf-11-infected cells (Table 1). PPV 014 and MC026L contain
a RING-H2 motif which is present in proteins from diverse
organisms. RING-H2 proteins are subunits of heteromeric
ubiquitin ligases (E3s) which affect multiple cellular processes
including cell cycle regulation and immune response (37).
PPVs and MOCV both lack genes present or conserved in
other poxviruses. These comprise homologues of most poxviral
genes likely involved in nucleotide metabolism, including ho-
mologues of OPV ribonucleotide reductase, thymidine kinase,
guanylate kinase, thymidylate kinase, and a putative ribonucle-
otide reductase cofactor, VACV glutaredoxin O2L (3). PPVs,
MOCV, and Melanoplus sanguinipes entomopoxvirus are the
only poxviruses known to lack a thymidine kinase gene. In
contrast, PPV 007, a gene not essential for growth of ORFV in
vitro, is a dUTPase gene missing in MOCV (22, 43, 72, 73).
Notably, PPVs and MOCV are the only ChPVs lacking homo-
logues of VACV B1R, a Ser/Thr protein kinase similar to
cellular VRK1 homologues and giving a temperature-sensitive
DNA-negative phenotype (61). PPVs and MOCV lack homo-
logues of VACV A50R DNA ligase, a gene also absent in
yatapoxviruses (81). Also absent in PPV and MOCV are serine
protease inhibitor and kelch-like gene families present in other
ChPVs. These gene families are known to affect host re-
sponses, including inflammation, apoptosis, complement acti-
vation, and coagulation (39), and are associated with virulence
(78). The lack of ChPV-like genes in both PPVs and MOCV
may reflect adaptation for specific tissue tropism, which is
notable considering that PPVs and MOCV appear to replicate
in cycling cells (17, 45).
Features similar in both PPV and MOCV—nucleotide com-
position, amino acid similarity, and gene content—suggest that
they are distinct from other known mammalian poxvirus gen-
era. Phylogenetic analysis of protein sequences also supports
the idea that, although divergent, PPVs and MOCV are dis-
tinct from other known mammalian ChPVs (Fig. 1).
Conclusions. PPV resembles other poxviruses in genome
organization and gene content, sharing specific genomic fea-
tures only with MOCV. Genome sequences of a BPSV strain
and two ORFV strains described here provide a comparative
view of PPV genomics and basic knowledge of viral functions
associated with virus replication and manipulation of cellular
responses. Significant differences occur between BPSV and
ORFV genomes, and these may account for differences in host
range. An improved understanding of PPV biology will permit
the engineering of novel vaccine viruses and expression vectors
with enhanced efficacy and greater versatility.
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ADDENDUM
Since the completion of the analysis presented here, an
additional ORFV genomic sequence has been deposited in the
patent database (accession no. AX754989).
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